These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 5158238

  • 1. Relationship of plasma concentrations of levodopa to clinical response in Parkinsonsim.
    Allen JG, Calne DB, Davies CA, Reid JL.
    Br J Pharmacol; 1971 Oct; 43(2):464P-465P. PubMed ID: 5158238
    [No Abstract] [Full Text] [Related]

  • 2. "On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine.
    Fahn S.
    Neurology; 1974 May; 24(5):431-41. PubMed ID: 4857104
    [No Abstract] [Full Text] [Related]

  • 3. A second report on Levodopa.
    Med Lett Drugs Ther; 1969 Sep 05; 11(18):73-5. PubMed ID: 5394281
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of Parkinsonism with a combination of levodopa and the decarboxylase inhibitor and RO 46-4602 (a comparison with levodopa treatment alone).
    Dupont E, Hansen E, Melsens S, Parkenberg H, Holm P.
    Acta Neurol Scand Suppl; 1972 Sep 05; 51():115-7. PubMed ID: 4514334
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Levodopa and amantadine in the treatment of Parkinsonism.
    Critchley E.
    Practitioner; 1972 Apr 05; 208(246):499-504. PubMed ID: 5031037
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Start hesitation--a side effect of long-term levodopa therapy.
    Ambani LM, Van Woert MH.
    N Engl J Med; 1973 May 24; 288(21):1113-5. PubMed ID: 4697941
    [No Abstract] [Full Text] [Related]

  • 12. Plasma concentration of levodopa in Parkinsonism before and after inhibition of peripheral decarboxylase.
    Reid JL, Calne DB, Vakil SD, Allen JG, Davies CA.
    J Neurol Sci; 1972 Sep 24; 17(1):45-51. PubMed ID: 4560435
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH.
    Neurology; 1970 Dec 24; 20(12):Suppl:31-5. PubMed ID: 4921586
    [No Abstract] [Full Text] [Related]

  • 15. Differentiation of tardive dyskinesias and drug-induced Parkinsonism.
    N Engl J Med; 1971 Jun 17; 284(24):1382-4. PubMed ID: 5576464
    [No Abstract] [Full Text] [Related]

  • 16. Importance and pathogenesis of abnormal movements during L-dopa therapy of Parkinson's disease.
    Barbeau A.
    Neurology; 1970 Apr 17; 20(4):377. PubMed ID: 5534982
    [No Abstract] [Full Text] [Related]

  • 17. Levodopa and parkinsonism: clinical impressions.
    Yahr MD.
    Clin Pharmacol Ther; 1971 Apr 17; 12(2):332-4. PubMed ID: 5577481
    [No Abstract] [Full Text] [Related]

  • 18. Side effects of L-dopa treatment.
    Greenburg J.
    Pa Med; 1971 Apr 17; 74(4):55-6. PubMed ID: 5147645
    [No Abstract] [Full Text] [Related]

  • 19. Plasma levodopa and the "on-off" effect.
    Caine DB, Claveria LE, Allen JG.
    Adv Neurol; 1974 Apr 17; 5():341-4. PubMed ID: 4440583
    [No Abstract] [Full Text] [Related]

  • 20. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E, D'Andrea F, Signorelli CD.
    Sist Nerv; 1970 Apr 17; 22(2):99-108. PubMed ID: 5504563
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.